{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T17:43:12Z","timestamp":1761154992045},"reference-count":27,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2006,9,7]],"date-time":"2006-09-07T00:00:00Z","timestamp":1157587200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatric Blood &amp; Cancer"],"published-print":{"date-parts":[[2007,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Although delayed red cell engraftment and\/or hemolysis have been thoroughly documented in association with ABO incompatibility between donor and recipient in patients undergoing hematopoietic stem cell transplantation (HSCT), there are no studies defining the general, long term clinical outcome in a large group of pediatric patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We undertook a retrospective single center analysis of children undergoing pediatric allogeneic stem cell transplantation to determine the influence of ABO donor\/recipient incompatibility. Outcome was analyzed according to donor type and included survival, graft versus host disease (GvHD), relapse, days of infection, antibiotic use, transfusion requirement and duration of hospital stay.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Two hundred and sixteen children (136 males; 80 females, aged 0\u201319) transplanted between January 1992 and December 2003 were included in the study. Indications for transplantation were hematological malignancies (n\u2009=\u2009179) and aplastic conditions (n\u2009=\u200937). ABO compatibility was documented in 121 donor\/recipient pairs. ABO incompatibility was documented in 95 donor\/recipient pairs with 40 major, 40 minor and 15 bi\u2010directional incompatible pairs. ABO incompatibility did not influence survival rate (<jats:italic>P<\/jats:italic>\u2009=\u20090.3762), the incidence of GvHD (<jats:italic>P<\/jats:italic>\u2009=\u20090.253) or rate of relapse (<jats:italic>P<\/jats:italic>\u2009=\u20090.930). Recovery of leucocytes was influenced by ABO incompatibility (<jats:italic>P<\/jats:italic>\u2009=\u20090.0493), but the rate of infection, transfusion requirements and duration of hospital stay are not.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>In the pediatric setting, ABO major and\/or minor mismatch between donor and recipient did not significantly influence the outcome of HSCT. The choice of donor should be determined by the degree of HLA match and CMV status in preference to ABO blood group compatibility. Pediatr Blood Cancer 2007;49:313\u2013317. \u00a9 2006 Wiley\u2010Liss, Inc.<\/jats:p><\/jats:sec>","DOI":"10.1002\/pbc.21025","type":"journal-article","created":{"date-parts":[[2006,9,7]],"date-time":"2006-09-07T18:52:05Z","timestamp":1157655125000},"page":"313-317","source":"Crossref","is-referenced-by-count":29,"title":["ABO incompatible stem cell transplantation in children does not influence outcome"],"prefix":"10.1002","volume":"49","author":[{"given":"A.M.","family":"Helming","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Brand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Wolterbeek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.J.D.","family":"van Tol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.M.","family":"Egeler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.M.","family":"Ball","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,9,7]]},"reference":[{"key":"e_1_2_6_2_2","first-page":"655","volume-title":"Clinical bone marrow and blood stem cell transplantation","author":"Dodds A","year":"2000"},{"key":"e_1_2_6_3_2","first-page":"4605","article-title":"Comparison of techniques for dealing with major ABO incompatible marrow transplants","volume":"19","author":"Bensinger WI","year":"1987","journal-title":"Transplant Proc"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-198204000-00017"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1703135"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.6.1687"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2002.00027.x"},{"key":"e_1_2_6_8_2","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1182\/blood.V67.1.177.177","article-title":"Donor derived red cell blood antibodies and immune hemolysis after allogeneic bone marrow transplantation","volume":"67","author":"Hows J","year":"1986","journal-title":"Blood"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2001.02734.x"},{"key":"e_1_2_6_10_2","first-page":"539","article-title":"Graft versus host disease and donor directed hemagglutinin titers after ABO\u2010mismatched related and unrelated allografts: Evidence for a graft versus plasma cell effect","volume":"30","author":"Mielcarek M","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"e_1_2_6_11_2","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1182\/blood.V75.1.290.290","article-title":"Pure red cell aplasia of long duration complicating major ABO\u2010incompatible bone marrow transplantation","volume":"75","author":"Gmur J","year":"1990","journal-title":"Blood"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1703621"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1704816"},{"key":"e_1_2_6_14_2","unstructured":"Kwaliteitsinstituut voor gezondheidszorg CBO.Richtlijn Bloedtransfusie. ISBN: 90\u20108523\u2010010\u20101;2004:139\u2013143."},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01969527"},{"key":"e_1_2_6_16_2","first-page":"825","article-title":"1994 consensus conference on acute GvHD grading","volume":"15","author":"Przepiorka D","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"e_1_2_6_17_2","first-page":"374b","article-title":"ABO system incompatibility and graft versus host disease (GvHD) frequency in bone marrow transplanted patients (abstract)","volume":"98","author":"Barone B","year":"2001","journal-title":"Blood"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2001.02734.x"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2003.00465.x"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-198204000-00017"},{"key":"e_1_2_6_21_2","first-page":"S153","article-title":"Pure red cell aplasia mimicking graft failure in a child following fludarabine based conditioning and allogeneic stem cell transplantation for homozygous beta\u2010thalassemia","volume":"33","author":"Ball LM","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1702629"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2002.03268.x"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1998.38398222864.x"},{"key":"e_1_2_6_25_2","first-page":"892","article-title":"Delayed erythropoiesis after major ABO\u2010incompatible bone marrow transplantation: Report of a case","volume":"89","author":"Tang JL","year":"1990","journal-title":"J Formos Med Assoc"},{"key":"e_1_2_6_26_2","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1182\/blood.V75.1.290.290","article-title":"Pure red cell aplasia of long duration complicating major ABO\u2010incompatible bone marrow transplantation","volume":"75","author":"Gmur J","year":"1990","journal-title":"Blood"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1704816"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1703706"}],"container-title":["Pediatric Blood &amp; Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpbc.21025","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/pbc.21025","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T01:01:46Z","timestamp":1697677306000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pbc.21025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9,7]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["10.1002\/pbc.21025"],"URL":"https:\/\/doi.org\/10.1002\/pbc.21025","archive":["Portico"],"relation":{},"ISSN":["1545-5009","1545-5017"],"issn-type":[{"value":"1545-5009","type":"print"},{"value":"1545-5017","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,9,7]]}}}